Effects of Milk Powder Intervention on Blood Glucose Control and Fluctuation in Middle-aged and Elderly People With Pre-diabetes
Effects of Daily Supplementation With Milk Powder on Blood Glucose Control and Fluctuation in Middle-aged and Older Adults: A Randomized Control Trial
1 other identifier
interventional
110
0 countries
N/A
Brief Summary
This study aims to conduct a 8-week intervention involving one formula milk powder for middle-aged and elderly individuals with pre-diabetes, assessing its impact on blood glucose control and fluctuations in comparison to interventions using regular milk powder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2025
CompletedFirst Posted
Study publicly available on registry
March 7, 2025
CompletedStudy Start
First participant enrolled
April 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedApril 3, 2025
March 1, 2025
8 months
March 3, 2025
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
fasting blood glucose
At baseline, and 8 weeks, investigators will use automatic electrochemiluminescence analyzer to examine fasting blood glucose.
up to 8 weeks
2h-piAUC after standardized breakfast
the positive increment of area under curve in 2 hours after standardized breakfast standardized breakfast, measured by continuous glucose monitoring at baseline, and 8 weeks.
up to 8 weeks
TIR (time in range)
TIR refers to the time when blood glucose is controlled within a reasonable ( target ) range (3.9\~10.0 mmol/L), measured by continuous glucose monitoring at baseline and 8 weeks.
up to 8 weeks
Secondary Outcomes (7)
HbA1c
up to 8 weeks
weight
up to 8 weeks
intestinal bacteria
up to 8 weeks
lipid metabolism
up to 8 weeks
sleep quality
up to 8 weeks
- +2 more secondary outcomes
Study Arms (2)
fortified formula milk powder group
EXPERIMENTALFortified formula milk powder is supplemented with fiber, bitter gourd powder,mulberry leaves extract, whitekidney beans extract, and probiotics, and packaged in 25-gram sachets. The milk powder is consumed orally, two sachets per day for a duration of 8 weeks.
regular milk powder group
PLACEBO COMPARATORRegular milk powder does not contain and additional supplementation, and the color, flavor, shape, taste, and weight are same with the formula milk powder.
Interventions
Fortified formula milk powder is supplemented with fiber, bitter gourd powder,mulberry leaves extract, whitekidney beans extract, and probiotics, and packaged in 25-gram sachets. The milk powder is consumed orally, two sachets per day for a duration of 8 weeks.
Regular milk powder does not contain and additional supplementation, and the color, flavor, shape, taste, and weight are same with the formula milk powder.
Eligibility Criteria
You may qualify if:
- Age between 40 and 75 years, regardless of gender.
- Impaired fasting glucose (5.6 mmol/L ≤ FPG \< 6.9 mmol/L) or glycated hemoglobin (HbA1c) between 5.7-6.4% (39-47 mmol/mol).
- Resided in Guangzhou for the past six months and no plans to relocate or travel outside the city in the next month.
- Signed informed consent form and voluntarily agreed to participate in the project.
You may not qualify if:
- Patients with a confirmed diagnosis of diabetes who are currently taking glucose-lowering medications (e.g., insulin, GLP-1 receptor agonists, or SGLT2 inhibitors).
- Individuals with lactose intolerance or dairy product intolerance.
- Pregnant, planning to become pregnant within the next three months, or currently breastfeeding.
- Weight change \> 5% in the past three months or plans to lose weight or change dietary habits.
- Alcohol consumption \> 40g/day.
- Individuals with communication barriers, cognitive impairments, or other conditions that may prevent them from completing the study procedures.
- Severe diseases that may affect participation in the study, including but not limited to endocrine disorders, severe cardiovascular or cerebrovascular diseases, cancer, metabolic diseases, etc.
- Participation in or current involvement in other clinical trials within the past three months.
- No use of antibiotic medications within the past three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huilian Zhulead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 3, 2025
First Posted
March 7, 2025
Study Start
April 10, 2025
Primary Completion
December 20, 2025
Study Completion
March 30, 2026
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share